Патрик Холфорд - Скажи НЕТ диабету. Готовый план действий

53

W. C. Knowler, «Reduction in the incidence of type-2 diabetes with lifestyle intervention or metformin», New England Journal of Medicine, 2002 Feb 7; 346 (6): 393–403

T. Wu, et al., «Associations of serum C-reactive protein with fasting insulin, glucose and glycosylated haemoglobin», American Journal of Epidemiology, 2002; 155: 65–71

W. C. knowler, et al., «Diabetes in the Pima Indians: incidence, risk factors and pathogenesis», Diabetes and Metabolism Review, 1990; 6: 1–27

Dr. Charles Clarke and Maureen Clarke, Diabetes Revolution, Vermillion, 2008

S. Eyre, “Overlapping genetic susceptibility variants between three autoimmune disorders: Rheumatoid arthritis, type-1 diabetes and coeliac disease», Arthritis Research and Therapy, 2010 Sep 20; 12 (5): R175 (Epub ahead of print)

S. Eyre, “Overlapping genetic susceptibility variants between three autoimmune disorders: Rheumatoid arthritis, type-1 diabetes and coeliac disease», Arthritis Research and Therapy, 2010 Sep 20; 12 (5): R175 (Epub ahead of print)

C. C. Patterson, «Incidence trends for childhood type-1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20», Lancet, 2009 Jun; 373 (9680): 2027–33

F. W. Scott, et al., «Milk and type-1 diabetes: Examining the evidence and broadening the focus», Diabetes Care, 1996; 19: 379–83

E. Savilahti and K.M. Saarinen, «Early infant feeding and type-1 diabetes», European Journal of Nutrition, 2009 Mar; 48 (4): 243–9

P.S. Clyne and A. Kulczycki, «Human breast milk contains bovine IgG: Relationship to infant colic?» Pediatrics 1991; 87: 439–44

M. Nilsson, et al., “And insulinemia in healthy subjects after lactose equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins», American Journal of Clinical Nutrition, 2004 Nov; 80 (5): 1246

M. Maglio et al, «The great majority of children with type-1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine», Diabetes, 2009 Jul; 58 (7): 1578–1584

D. Hansen, «Clinical benefit of a gluten-free diet in type-1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years’ follow-up», Diabetes Care, 2006 Nov; 29 (11): 2452–6

A. Grigorian et al., «Control of T Cell-mediated autoimmunity by Metabolite Flux to N-Glycan Biosynthesis», Journal of Biological Chemistry, 2007 May; 282: 20027–35

E. Hypponen, et al., «Intake of vitamin D and risk of type-1 diabetes: a birth-cohort study», Lancet, 2001 Nov; 358 (9292): 1500–03

S. J. Richardson, et al., «The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type-1 diabetes», Diabetologia, 2009 Jun; 52 (6): 1143–51

G. Dahlquist, «Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis», Diabetologia, 2006 Jan; 49 (1): 20–4

Editorial «Type-2 diabetes: time to change our approach», Lancet 2010, Jun; 375 (9733): 2193

M. Monami, et al., «Metformin and cancer occurrence in insulin-treated type-2 diabetic patients», Diabetes Care. 2010 oct. (Только в электронном виде); см. также M. S. McFarland и R. Cripps, «Diabetes Mellitus and increased Risk of Cancer: Focus on Metformin and the insulin analogs», Pharmacotherapy, 2010; 30 (11): 1159–1178

D. Buvat «Letter: Use of metformin is cause of vitamin B12 deficiency», American Family Physician, 2004 Jun; 69 (2): 264

J. Vidal-alaball, «Reduced serum vitamin B-12 in patients taking metformin», BMJ, 2010 May; 40: c2198

A.D. Smith, et al., «Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial», Public Library of Science One, Опубликовано пока только он-лайн: 10.1371/journal.pone.0012244

S.E. Nissen и K. Wolski, «Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes», New England Journal of Medicine, 2007 Jun; 356 (24): 2457–71

J. Burne, «Should you still be taking avandia? As the diabetes drug is linked to worrying side effects, some experts say there’s a safer alternative», Daily Mail, July 26, 2010

P.D. Home, et al., «Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type-2 diabetes (RECORD): a multicentre, randomised, open-label trial», Lancet, 2009 Jun 20; 373 (9681): 2125–35